Date de publication: 3 mai 2006
Promoteur – Intermédiaire Financier
Chiesi Farmaceutici SpA is the holding company of a medium-sized privately owned pharmaceutical group based in Parma. The promoter is dedicated to the research, development and commercialisation of products in four core therapeutic areas: respiratory, cardiovascular, musculo-skeletal inflammation and neonatology.Lieu
Description
The present project represents the first operation with Chiesi Farmaceutici and is aimed at assisting the construction of a new R&D centre as well as the upgrade of the equipment, allowing the rationalization of Chiesi's R&D activities and their future development.
Objectifs
Chiesi is one of the leading pharmaceutical companies in Italy. Although being a mid-sized privately owned group, Chiesi invests every year a significant portion of total turnover (13% in 2004) in R&D. The investments will strengthen the regional and local endowment of R&D and contribute to the EU's private sector investments in R&D, in line with the Bank's i2i plan concerning the promotion and strengthening of scientific research.
Commentaires
Research & Development
Secteur(s)
Montant BEI envisagé (montant approximatif)
EUR 30 million
Coût total (montant approximatif)
EUR 60 million
Aspects environnementaux
To be verified during appraisal.
Passation des marchés
To be verified during appraisal.
Statut
Signé - 3/04/2009
Clause de non-responsabilité
Avant d’être approuvés par le Conseil d’administration et avant la signature des prêts correspondants, les projets font l’objet d’une instruction et de négociations. Par conséquent, les informations et données fournies sur cette page sont indicatives.
Elles sont fournies à des fins de transparence uniquement et ne peuvent être considérées comme représentant la politique officielle de la BEI (voir également les notes explicatives).